                         SEQUENCE LISTING

<110>  Nanyang Technological University
 
<120>  INFLAMMATION-RESPONSIVE ANTI-INFLAMMATORY HYDROGELS

<130>  SP101987WO

<150>  SG10201911767R
<151>  2019-12-06

<160>  40    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GRCR Spacer

<400>  1

Gly Arg Cys Arg 
1               


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCRG spacer

<400>  2

Gly Cys Arg Gly 
1               


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GRCD spacer

<400>  3

Gly Arg Cys Asp 
1               


<210>  4
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCDR spacer

<400>  4

Gly Cys Asp Arg 
1               


<210>  5
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCDG spacer

<400>  5

Gly Cys Asp Gly 
1               


<210>  6
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GDCD spacer

<400>  6

Gly Asp Cys Asp 
1               


<210>  7
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCDD spacer

<400>  7

Gly Cys Asp Asp 
1               


<210>  8
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCRD spacer

<400>  8

Gly Cys Arg Asp 
1               


<210>  9
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCRR spacer

<400>  9

Gly Cys Arg Arg 
1               


<210>  10
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GPRSLSG substrate

<400>  10

Gly Pro Arg Ser Leu Ser Gly 
1               5           


<210>  11
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  LGRMGLPGK substrate

<400>  11

Leu Gly Arg Met Gly Leu Pro Gly Lys 
1               5                   


<210>  12
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  AVRWLLTA substrate

<400>  12

Ala Val Arg Trp Leu Leu Thr Ala 
1               5               


<210>  13
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GPQGIWGQ substrate

<400>  13

Gly Pro Gln Gly Ile Trp Gly Gln 
1               5               


<210>  14
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  APEEIMDRQ substrate

<400>  14

Ala Pro Glu Glu Ile Met Asp Arg Gln 
1               5                   


<210>  15
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PMAVVQSVP substrate

<400>  15

Pro Met Ala Val Val Gln Ser Val Pro 
1               5                   


<210>  16
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GRRGLG substrate

<400>  16

Gly Arg Arg Gly Leu Gly 
1               5       


<210>  17
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DGFLGDD substrate

<400>  17

Asp Gly Phe Leu Gly Asp Asp 
1               5           


<210>  18
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCRR-KGPRSLSGK-RRCG

<400>  18

Gly Cys Arg Arg Lys Gly Pro Arg Ser Leu Ser Gly Lys Arg Arg Cys 
1               5                   10                  15      


Gly 
    


<210>  19
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GPQGIWGQ-DRCG

<400>  19

Gly Pro Gln Gly Ile Trp Gly Gln Asp Arg Cys Gly 
1               5                   10          


<210>  20
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GPRSLSGRRCG

<400>  20

Gly Pro Arg Ser Leu Ser Gly Arg Arg Cys Gly 
1               5                   10      


<210>  21
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCRR-GPRSLSG-RRCG

<400>  21

Gly Cys Arg Arg Gly Pro Arg Ser Leu Ser Gly Arg Arg Cys Gly 
1               5                   10                  15  


<210>  22
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCRD-GPQGIWGQ-DRCG

<400>  22

Gly Cys Arg Asp Gly Pro Gln Gly Ile Trp Gly Gln Asp Arg Cys Gly 
1               5                   10                  15      


<210>  23
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCRR-LGRMGLPGK-RRCG

<400>  23

Gly Cys Arg Arg Leu Gly Arg Met Gly Leu Pro Gly Lys Arg Arg Cys 
1               5                   10                  15      


Gly 
    


<210>  24
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCRR-AVRWLLTA-RRCG

<400>  24

Gly Cys Arg Arg Ala Val Arg Trp Leu Leu Thr Ala Arg Arg Cys Gly 
1               5                   10                  15      


<210>  25
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCRR-GPQGIWGQ-RRCG

<400>  25

Gly Cys Arg Arg Gly Pro Gln Gly Ile Trp Gly Gln Arg Arg Cys Gly 
1               5                   10                  15      


<210>  26
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCRD-LGRMGLPGK-DRCG

<400>  26

Gly Cys Arg Asp Leu Gly Arg Met Gly Leu Pro Gly Lys Asp Arg Cys 
1               5                   10                  15      


Gly 
    


<210>  27
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCRD-KGPRSLSGK-DRCG

<400>  27

Gly Cys Arg Asp Lys Gly Pro Arg Ser Leu Ser Gly Lys Asp Arg Cys 
1               5                   10                  15      


Gly 
    


<210>  28
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCRD-AVRWLLTA-DRCG

<400>  28

Gly Cys Arg Asp Ala Val Arg Trp Leu Leu Thr Ala Asp Arg Cys Gly 
1               5                   10                  15      


<210>  29
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GCRR-KSSRGGPLK-RRCG

<400>  29

Gly Cys Arg Arg Lys Ser Ser Arg Gly Gly Pro Leu Lys Arg Arg Cys 
1               5                   10                  15      


Gly 
    


<210>  30
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  KGPRSLSGK

<400>  30

Lys Gly Pro Arg Ser Leu Ser Gly Lys 
1               5                   


<210>  31
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GRCR-PMAVVQSVP-RCRG

<400>  31

Gly Arg Cys Arg Pro Met Ala Val Val Gln Ser Val Pro Arg Cys Arg 
1               5                   10                  15      


Gly 
    


<210>  32
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GRCR-GPRSLSG-RCRG

<400>  32

Gly Arg Cys Arg Gly Pro Arg Ser Leu Ser Gly Arg Cys Arg Gly 
1               5                   10                  15  


<210>  33
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GXXX Spacer seqiuence


<220>
<221>  MISC_FEATURE
<222>  (2)..(4)
<223>  Xaa is independently Glycine, Cysteine, Aspartic acid, or 
       Arginine.

<400>  33

Gly Xaa Xaa Xaa 
1               


<210>  34
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  XXXG


<220>
<221>  MISC_FEATURE
<222>  (1)..(3)
<223>  Xaa is independently Glycine, Cysteine, Aspartic acid, or 
       Arginine.

<400>  34

Xaa Xaa Xaa Gly 
1               


<210>  35
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GRCR-APEEIMDRQ-RCRG

<400>  35

Gly Arg Cys Arg Ala Pro Glu Glu Ile Met Asp Arg Gln Arg Cys Arg 
1               5                   10                  15      


Gly 
    


<210>  36
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GRCR-GPQGIWGQ-RCRG

<400>  36

Gly Arg Cys Arg Gly Pro Gln Gly Ile Trp Gly Gln Arg Cys Arg Gly 
1               5                   10                  15      


<210>  37
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GRCR-GRRGLG-RCRG

<400>  37

Gly Arg Cys Arg Gly Arg Arg Gly Leu Gly Arg Cys Arg Gly 
1               5                   10                  


<210>  38
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GRCR- DGFLGDD-RCRG

<400>  38

Gly Arg Cys Arg Asp Gly Phe Leu Gly Asp Asp Arg Cys Arg Gly 
1               5                   10                  15  


<210>  39
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  xM scrambled

<400>  39

Gly Cys Arg Arg Ser Ser Arg Gly Gly Pro Leu Arg Arg Cys Gly 
1               5                   10                  15  


<210>  40
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  M scrambled

<400>  40

Ser Ser Arg Gly Gly Pro Leu Arg Arg Cys Gly 
1               5                   10      


